Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Hathaway

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Clinical Investigation|December 1, 1991
Lipoproteins of human peripheral lymph. Apolipoprotein AI-containing lipoprotein with alpha-2 electrophoretic mobilityD Reichl, C B Hathaway, J M Sterchi, et al.
The American Journal of Physiology|March 1, 1996
Central trigeminal effects of somatostatin and etorphine on adrenal and autonomic function in the catD A Bereiter, A P Benetti, D F Bereiter, et al.
Neuroscience|February 1, 1996
Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonistK Tsou, K A Lowitz, A G Hohmann, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Clinical Investigation|December 1, 1991
Lipoproteins of human peripheral lymph. Apolipoprotein AI-containing lipoprotein with alpha-2 electrophoretic mobilityD Reichl, C B Hathaway, J M Sterchi, et al.
The American Journal of Physiology|March 1, 1996
Central trigeminal effects of somatostatin and etorphine on adrenal and autonomic function in the catD A Bereiter, A P Benetti, D F Bereiter, et al.
Neuroscience|February 1, 1996
Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonistK Tsou, K A Lowitz, A G Hohmann, et al.
Pageof 2